(Q36680085)

15 August 2017

1 reference

title

Tumor antigens as surrogate markers and targets for therapy and vaccines (English)

1 reference

15 August 2017

1

Angus Dalgleish

1 reference

15 August 2017

2

Hardev Pandha

1 reference

15 August 2017

1 January 2007

1 reference

Advances in Cancer Research

15 August 2017

1 reference

15 August 2017

96

1 reference

15 August 2017

175-190

1 reference

Antiandrogen, vaccine and combination therapy in patients with nonmetastatic hormone refractory prostate cancer

15 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996009-6

7 January 2021

Immunobiology of dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996009-6

7 January 2021

Lymphocyte homing and homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996009-6

7 January 2021

Therapeutic vaccines for melanoma: current status

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996009-6

7 January 2021

The makings of a tumor rejection antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996009-6

7 January 2021

CD8(+) T cell responses against a dominant cryptic HLA-A2 epitope after NY-ESO-1 peptide immunization of cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996009-6

7 January 2021

New developments in dendritic cell-based vaccinations: RNA translated into clinics

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996009-6

7 January 2021

Creation of human tumour cells with defined genetic elements

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996009-6

7 January 2021

Inhibition of telomerase limits the growth of human cancer cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996009-6

7 January 2021

Dissecting cytotoxic T cell responses towards the NY-ESO-1 protein by peptide/MHC-specific antibody fragments

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996009-6

7 January 2021

Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996009-6

7 January 2021

Mycobacterium vaccae (SRL172): a potential immunological adjuvant evaluated in rat prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996009-6

7 January 2021

Adjuvant autologous renal tumour cell vaccine and risk of tumour progression in patients with renal-cell carcinoma after radical nephrectomy: phase III, randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996009-6

7 January 2021

Memory CD8+ T cell differentiation: initial antigen encounter triggers a developmental program in naïve cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996009-6

7 January 2021

Specific association of human telomerase activity with immortal cells and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996009-6

7 January 2021

Expression of TERT in early premalignant lesions and a subset of cells in normal tissues.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996009-6

7 January 2021

Delayed disease progression after allogeneic cell vaccination in hormone-resistant prostate cancer and correlation with immunologic variables

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996009-6

7 January 2021

Identification of tumor-associated antigens by screening phage-displayed human cDNA libraries with sera from tumor patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996009-6

7 January 2021

Cytotoxic T cell immunity against telomerase reverse transcriptase in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996009-6

7 January 2021

Dendritic-cell-based therapeutic vaccination against cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996009-6

7 January 2021

A listing of human tumor antigens recognized by T cells: March 2004 update

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996009-6

7 January 2021

Rituximab: expanding role in therapy for lymphomas and autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996009-6

7 January 2021

A listing of human tumor antigens recognized by T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996009-6

7 January 2021

Human neoplasms elicit multiple specific immune responses in the autologous host

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996009-6

7 January 2021

The spontaneous CD8+ T-cell response to HLA-A2-restricted NY-ESO-1b peptide in hepatocellular carcinoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996009-6

7 January 2021

A survey of telomerase activity in human cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996009-6

7 January 2021

Telomerase mRNA-transfected dendritic cells stimulate antigen-specific CD8+ and CD4+ T cell responses in patients with metastatic prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996009-6

7 January 2021

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996009-6

7 January 2021

NY-ESO-1 is highly expressed in poor-prognosis multiple myeloma and induces spontaneous humoral and cellular immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996009-6

7 January 2021

Naïve CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996009-6

7 January 2021

Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996009-6

7 January 2021

Vaccination of cancer patients against telomerase induces functional antitumor CD8+ T lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996009-6

7 January 2021

The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996009-6

7 January 2021

Functional and structural characteristics of NY-ESO-1-related HLA A2-restricted epitopes and the design of a novel immunogenic analogue

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996009-6

7 January 2021

10.1016/S0065-230X(06)96009-6

Identifiers

DOI

1 reference

15 August 2017

1 reference

PubMed ID

17161680